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INTRODUCTION
In recent decades, there has been a dramatic increase in rec-
ognition of prepubertal- and adolescent-onset bipolar disorder
(BD). As there is no clear consensus among experts regarding
the clinical presentation of BD, diagnostic symptom criteria,
or clinical course in adolescents and children, the diagnosis
and treatment of BD in prepubertal and adolescent youth re-
mains a controversial issue. Some investigators have report-
ed that the phenomenology of adolescent mania is similar to
that of adult mania (1, 2), while other researchers have report-
ed that adolescent patients display a significantly higher rate
of mixed episodes and a significantly lower rate of psychotic
features than adult patients (3). The clinical presentation of
BD in prepubertal groups has been debated, as well. Previ-
ous studies suggest that the presentation of prepubertal BD is
atypical when judged by adult standards and that prepubertal
BD is different from that of adolescent BD. The atypical fea-
tures of prepubertal BD, which have been proposed by rese-
archers, are a mixed presentation rather than the classic eup-
horic, grandiose presentation with an insidious onset and a
chronic course (4-7). A research roundtable meeting was con-
vened to discuss the controversial areas in the diagnosis of
prepubertal BD at the National Institute of Mental Health
(NIMH), Bethesda, MD, USA on April 27, 2000. Experien-
ced clinicians and researchers with expertise on prepubertal
BD agreed that the diagnosis of BD in prepubertal popula-
tions is possible with currently available psychiatric assessm-
ent instruments. Further, in addition to the phenotypes that
fit the Diagnostic Statistical Manual of Mental Disorders, Fo-
urth Edition (DSM-IV) (8) criteria for bipolar I disorder, there
exists other phenotypes that do not meet the DSM-IV crite-
ria (9). Leibenluft et al. (10) introduced a framework for the
classification of juvenile bipolar spectrum disorders into nar-
row, intermediate, and broad phenotypes. The phenotypic
system is based on the DSM-IV episode and duration crite-
ria, as well as the presence or absence of the classic manic sy-
mptoms of elevated mood and grandiosity. 
Although BD is more common in children than has been
acknowledged previously, prepubertal BD remains difficult
to diagnose (11-13). Previous studies about the clinical course
of early onset BD have reported that children with BD tend
to show a chronic course, severe functional impairment, and
other psychiatric complications (14-17). Therefore, it is im-
portant to identify the age-specific manifestations of BD and
to define the diagnostic possibilities for prepubertal and ado-
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Differences of Clinical Characteristics and Phenotypes between 
Prepubertal- and Adolescent-Onset Bipolar Disorders
The aim of this study is to describe the clinical characteristics of prepubertal- and ado-
lescent-onset bipolar disorder (BD) and to identify any clinical differences between
patients with prepubertal- and adolescent-onset BD. We analyzed the clinical records
of 53 inpatients with BD. These patients were divided into prepubertal-onset and ado-
lescent-onset groups. We also divided the subjects into narrow, intermediate, and
broad phenotypes according to the definitions proposed by Leibenluft and colleagues.
Of the total sample, 16 patients (30.2%) were in the prepubertal-onset group and
37 (69.8%) were in the adolescent-onset group. Patients with prepubertal-onset BD
were more likely to display an insidious clinical presentation, atypical features, and
comorbid psychopathology. And the majority of the subjects, especially in the pre-
pubertal-onset group, were classified under the intermediate and broad phenotypes.
These results suggest that the clinical presentation of BD with prepubertal-onset is
different from that of adolescent-onset BD. It is inferred that a significant number of
patients with prepubertal- and adolescent-onset BD do not meet DSM-IV criteria for
mania or hypomania from the results of this study.
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lescent groups with BD. Early detection and intervention co-
uld improve treatments and clinical outcomes during these
important life stages.
The aim of our study is to describe the clinical character-
istics of prepubertal- and adolescent-onset BD, and to identi-
fy any clinical differences between prepubertal- and adoles-
cent-onset groups.
MATERIALS AND METHODS
Subjects and data  
We implemented a retrospective study design. Specifically,
all of the patients who had been hospitalized and diagnosed
with BD between January 2004 and January 2009 at the Chi-
ld and Adolescent Psychiatry Service Unit at Samsung Med-
ical Center, Seoul, Republic of Korea were included in the
analysis. A total of 53 subjects were identified and diagnosed
with bipolar I disorder, bipolar II disorder, or BD NOS based
on the DMS-IV diagnostic criteria by experienced child and
adolescent psychiatrists. The subjects were divided into two
age groups on the basis of recommendations published by a
number of authors (7, 18, 19): the prepubertal-onset group
(who displayed mood episodes beginning before age 13) and
the adolescent-onset group (who displayed mood episodes be-
ginning at or above age 13). We analyzed a range of clinical
variables drawn from the medical records of the psychiatrists
in charge of the patients. These variables included the age at
onset of symptoms of BD, the age at diagnosis, the symptoms
in the clinical course, family history, and psychiatric comor-
bidities. The symptoms at onset, which the subjects had sh-
own dominantly in the initial phase, fell into four categories:
irritability and aggressive behavior, depressive symptoms,
manic symptoms, and mood swings and fluctuations. The
symptoms at the time of hospitalization were divided into
four categories based on the DSM-IV episode criteria: mania,
hypomania, mixed symptoms, and depression. The treatment
before and after the diagnosis of BD were also examined. We
reviewed psychological evaluations, including the Korean
Educational Development Institute-Wechsler Intelligence
Scale for children-III (KEDI-WISC-III) and the Korean
Child Behavior Checklist (K-CBCL) (20). 
This study was conducted with the approval of the Institu-
tional Review Board at the Samsung Medical Center (IRB file
NO 2008.09.068). Informed consent was exempted. 
Classification of subjects into phenotypes
All subjects were classified into narrow, intermediate, and
broad phenotypes according to the definitions proposed by
Leibenluft et al. The narrow phenotype was assigned to those
who met the full DSM-IV diagnostic criteria for mania or hy-
pomania and who also had the hallmark symptoms of elevat-
ed mood or grandiosity. The intermediate phenotypes inclu-
ded two subcategories: those individuals with hallmark symp-
toms of a short duration and those with episodic irritable ma-
nia or hypomania that meets the duration criteria, but with-
out elation. The broad phenotype consisted of non-episodic
symptoms of severe irritability and hyperarousal, however, this
phenotype does not include the hallmark symptoms of elated
mood or grandiosity (10).
Statistical analysis
Data were analyzed using SPSS 16.0 R Software for Win-
dows. We used the chi-square test and the Mann-Whitney
test to evaluate the differences in clinical variables between




We assigned 16 patients (30.2%) to the prepubertal-onset
group and 37 (69.8%) to the adolescent-onset group. Table
1 shows the mean age at the onset of symptoms of BD, the
mean age at initial diagnosis, and the mean age at hospitaliza-
tion of our sample. The duration between the onset of symp-
toms and the diagnosis of BD in the prepubertal-onset group
was significantly longer than that in the adolescent-onset gr-
oup (Table 1). There were significant gender differences bet-
ween the groups, and the majority of the prepubertal-onset
group was male. Specifically, 13 (81.2%) of the prepubertal
group were male and 18 (48.6%) of the adolescent group were
male (P=0.03). 
Clinical characteristics






Age at onset  9.81±1.87 14.14±1.23 <0.00
(yr, mean±SD)
Age at diagnosis  12.38±2.39 15.38±1.32 <0.00
(yr, mean±SD)
Age at hospitalization  12.50±2.45 15.59±1.24 <0.00
(yr, mean±SD)
Duration between at  31.50±11.95 15.62±11.48 <0.00
onset and at diagnosis 
(month, mean±SD)
Table 1. Clinical variables in prepubertal and adolescent-onset
bipolar disorder
*by Mann Whitney test.914 M. Song, H. Yoon, I. Choi, et al.
egorized as a tendency to exhibit irritability and aggressive
behavior, while the adolescent group tended to express depres-
sive symptoms. Many of the subjects in the prepubertal and
adolescent groups had presented with a mixed episode at the
time of admission. There were no differences between the gr-
oups with respect to family history of BD or major depressive
disorder. In the prepubertal-onset group, the rate of comorbid-
ity was higher than that of the adolescent-onset group and
attention-deficit/hyperactivity disorder was the most prevalent
comorbid disorder (Table 2). 
There were no differences between groups in intelligence
scores as assessed by the KEDI-WISC-III. The mean full sc-
ale IQ scores for the prepubertal and adolescent groups were
99.36 (SD=25.46) and 90.30 (SD=18.33), respectively. No
meaningful differences were detected between the groups in
K-CBCL scores. In both groups, all of the K-CBCL clinical
subscales other than the somatization subscale were greater
than 60, which tends to be predictive of clinically significant
psychopathology (Table 3) (21).
Classification of subjects into phenotypes
In the prepubertal-onset group, only three (18.8%) met the
DSM-IV criteria for mania or hypomania, and these three
were classified into the narrow phenotype. In the adolescent-
onset group, 12 (32.4%) met the DSM-IV criteria for mania
or hypomania, and they were classified into the narrow phe-
notype (Table 4). 
Treatment before and after diagnosis of bipolar disorder
Four subjects (25.0%) from the prepubertal-onset group
had been taking methylphenidate and 13 (35.1%) from the
adolescent-onset group had been taking antidepressants prior
to the diagnosis of BD. After the diagnosis of BD, the most
prevalent prescription in the adolescent-onset group was a mo-
od stabilizer with antipsychotics. There was tendency toward
monotherapy with either mood stabilizers or antipsychotics
in the prepubertal-onset group (Table 5). 
*by chi-square test.
BD, Bipolar affective disorder; MD, Major depression; ADHD, Atten-
tion-deficit/hyperactivity disorder; ODD, Oppositional defiant disorder;
CD, Conduct disorder; PDD, Pervasive developmental disorder;
PDDNOS, Pervasive developmental disorder, not otherwise specified;









Irritability, aggressive behavior 10 (62.5) 9 (24.3)
Elated mood, euphoria  2 (12.5) 6 (16.2)
Depression 3 (18.8) 18 (48.6)
Mood swing, fluctuation 1 (6.3) 4 (10.8)
Symptoms at hospitalization
Mania  3 (18.8) 5 (13.5)
Hypomania 0  (0) 1  (2.7)
Mixed 13 (81.2) 25 (67.6)
Depression 0 (0) 6 (16.2)
Psychotic feature at hospitalization 5 (31.2) 15 (40.5) 0.52
Family history 0.23
First or second degree of BD or MD 8 (50) 12 (32.4)
Comorbidity
No 2 (12.5) 17 (45.9) 0.02
Yes 14 (87.5) 20 (54.1)
ADHD 7 (43.8) 8 (21.6)
ODD/CD 4  (30.8) 4 (10.8)
Anxiety disorder 1 (6.3) 1 (2.7)
Tic disorder 1 (6.3) 1 (2.7)
PDD/PDDNOS 2 (12.5) 3 (8.1)
MR/BIF 3 (18.8) 5 (13.5)
Personality disorder 0 (0) 3 (8.1)
Eating diosrder 0 (0) 1 (2.7)
Table 2. Clinical characteristics in prepubertal and adolescent-
onset bipolar disorder
*by the Mann Whitney test. Value are given in mean±SD. 
CBCL, Child Behavior Checklist.
Subscales Prepubertal (n=16) Adolescent (n=37) P*
Social subscales
Total competence 28.69±19.43 35.92±14.83 0.49
Social 29.08±19.43 31.08±15.86 0.76
School 40.49±17.31 44.38±12.41 0.80
Clinical subscales
Withdrawn 64.23±11.51 64.46±12.39 0.94
Somatization 59.08±8.88 55.92±10.91 0.27
Anxious/depressed 67.69±8.69 64.92±8.35 0.55
Social problems 63.46±12.61 62.54±10.52 0.74
Thought problems 64.31±13.00 64.38±11.13 0.98
Attention problems 65.23±12.78 63.15±10.34 0.32
Delinquency 64.15±8.41 64.46±8.66 0.82
Aggression 66.08±10.91 62.46±9.68 0.27
Table 3. Comparison of T Scores for CBCL Subscales in prepu-
bertal and adolescent-onset bipolar disorder







Narrow phenotype 3 (18.8) 12 (32.4)
Intermediate phenotype 7 (43.8) 13 (35.1)
those with the hallmark  2 (12.5) 8 (21.6)
symptoms for a short duration
those with episodic irritable mania 5 (31.3) 5 (13.5)
or hypomania that meets the 
duration criteria without elation
Broad phenotype 6 (37.5) 12 (32.4)
Table 4. Classification of subjects into phenotypes depending on
research criteria*Prepubertal and Adolescent-Onset Bipolar Disorder 915
DISCUSSION
These results suggest that prepubertal-onset BD patients
tend to show an insidious clinical presentation, atypical fea-
tures, and more comorbid psychopathology than BD patients
with adolescent-onset. We infer that a significant number of
patients with prepubertal- and adolescent-onset BD do not
meet DSM-IV criteria for mania or hypomania from the re-
sults of this study. 
Many seriously disturbed children with affective dysregu-
lation and high levels of agitation and aggression present diag-
nostic and therapeutic challenges to clinicians. Recent research
suggests that children with chronic, continuous, severe irri-
tability or prolonged anger outbursts are often diagnosed with
BD (22). In our study, the prepubertal sample displayed sy-
mptoms, such as marked irritability and aggressive behavior
in the year or years prior to receiving a diagnosis of BD. Addi-
tionally, the duration between the onset and diagnosis of BD
in the prepubertal-onset group was longer than that of the
adolescent-onset group. This delay in diagnosis at early ages
may be due to the fact that the initial presentation of the pre-
pubertal BD is often not mood symptoms, but rather be-
havioral problems. Another possible reason for the delayed
diagnosis of BD at early ages may be a high frequency of com-
orbidity. In this study, we found that many patients with pre-
pubertal-onset BD had comorbid externalizing disorders,
such as attention-deficit hyperactivity disorder (ADHD) (43.8
%), as well as oppositional defiant disorder and conduct dis-
order (30.8%). Systemic studies show that rates of ADHD
range from 60% to 90% in pediatric patients with BD (7,
18). Clinical reports have estimated the rates of conduct dis-
order in manic children and adolescents with BD to range
from 17% to 69% (17, 23). Thus, it may be that the com-
bination of mood changes and disruptive behavior are a spe-
cific marker of BD syndrome in young patients (24).
Until now, there have been few studies that have applied
the proposed phenotypes of juvenile BD (10) to clinical sub-
jects. When we applied this criteria to the patients examined
in this study, the majority of the subjects, especially in the pre-
pubertal-onset group, were classified under the intermediate
and broad phenotypes, which did not meet the DSM-IV cri-
teria for either mania or hypomania. The results of the present
study correspond with a previous study that reported only
approximately 50% of child and adolescent bipolar patients
met DSM-IV criteria (4). In this study, 37% of the prepuber-
tal group and 32% of the adolescent group was classified as
the broad phenotype. Since the broad phenotype consists of
non-episodic symptoms of severe irritability without elated
mood or grandiosity, it is easy to confuse the broad phenotype
with childhood externalizing disorders. This phenotypic sys-
tem can help clinicians develop a more clear phenotypic des-
cription of prepubertal and adolescent BD and to re-evalu-
ate young patients who do not meet the DSM-IV criteria for
mania, but who do have mood symptoms, behavioral changes,
and functional impairment. Longitudinal studies that exam-
ine the clinical course of the broad phenotype are warranted
in order to find out whether this categorization represents a
homogenous subgroup of bipolar spectrum disorder.
Early detection of BD and recognition of comorbid disor-
ders is very important for determining the appropriate types
and sequences of treatments. In our study, four (25.0%) of the
prepubertal-onset group had been taking methylphenidate,
and 13 (35.1%) of the adolescent-onset group had been tak-
ing antidepressants prior to the diagnosis of BD. Stimulant
use to target ADHD symptoms in bipolar patients can be
problematic because of its potential to precipitate or exacer-
bate mood-related symptoms (25). Additionally, previous
work has suggested that there is concern that antidepressants
can worsen the clinical course of bipolar illness (26).
The CBCL is one of the best-studied, empirically derived,
checklists available to examine childhood psychopathology
(27). Recently it has been shown that the CBCL is useful in
distinguishing BD from ADHD. Additionally, children with
BD typically have high scaled scores in the Aggression, Atten-
tion Problems, Delinquency, Thought Problems, and Anx-
ious/Depressed subscales of the CBCL (28, 29). Although we
failed to find any differences in K-CBCL subscales between
groups, the results of this study support the previous studies.
It is important to consider a diagnosis of BD when assessing
children with high scores on these CBCL subscales even when
they do not fit any of DSM-IV diagnostic criteria.
This retrospective study has some limitations, such as the
lack of structured or semi-structured interviews for diagnosis.
Antipsychotics include aripiprazole, risperidone and quetiapine, Mood
stabilizer include lithium and divalproex, Antidepressant include fluoxe-
tine, paroxetine and escitalopram.
*by chi-square test, 
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P Onset of treatment
Treatment before BD diagnosis* 0.37
No 8 (50) 20 (54.1)
YES 8 (50) 15 (40.5)
MPH 3 (18.8) 1 (2.7)
Antidepressant 1 (6.2) 9 (24.3)
Antipsychotics with antidepressant 2 (12.5) 1 (2.7)
Antipsychotics with mood stabilizer  1 (6.2) 1 (2.7)
Mood stabilizer with antidepressant 0 (0) 1 (2.7)
Antidepressant with MPH 1 (6.2) 2 (5.4)
Treatment after BD diagnosis
�
>0.99
No 0 (0) 1 (2.7)
Yes 16 (100) 36 (97.3)
Mood stabilizer only 5 (31.2) 4 (10.8)
Antipsychotics only 5 (31.2) 5 (13.5)
Mood stabilizer and antipsychotics 4 (25) 27 (73)
Mood stabilizer and MPH 1 (6.2) 0 (0)
Antipsychotics and MPH 1 (6.2) 0 (0)
Table 5. Treatment before and after diagnosis of bipolar disorder916 M. Song, H. Yoon, I. Choi, et al.
In this study, however, we evaluated the clinical features of
the subjects intensively in the inpatient clinic for a month or
months. A minimum of two psychiatrists and a psychologist
participated in the diagnosis of the subjects. Additionally, it
is known that clinical assessment and structured interview are
highly consistent with each other (30). We divided the sub-
jects into prepubertal- and adolescent onset BD according to
the age. In order to define the prepubertal phase, it is required
to examine the secondary sex characteristics of the subjects.
The biological marker, such as Tanner stage could be used in
the following study. In the results of research examining the
clinical presentation of BD, it has been demonstrated that it is
ideal to evaluate patients with BD who do not have any other
psychiatric disorders. Nonetheless, the examination of pure
bipolar patients in prepubertal and adolescent populations is
complicated due to the high rates of comorbidity common
among individuals with BD. Further research must be con-
ducted to separate the effects of comorbid psychiatric disor-
ders on the clinical course of BD in young patients.
BD in prepubertal and adolescent populations is a serious,
recurrent, and debilitating psychiatric concern. Too often BD
is not considered as a possible diagnosis in children, and de-
layed diagnosis may have negative effects on the clinical course
and prognosis for children. Alternative diagnostic criteria and
assessment instruments for prepubertal and adolescent BD
need to be developed. 
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